SCHEMBL7108916

SCHEMBL7108916

COC1=CN(CCCN2CCN(c3ccccc3F)CC2)S(=O)(=O)c2cccc(OC)c21

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 7/20 0.53
DRD2 P14416 7/20 0.52
HTR1A P08908 5/20 0.52
HTR2A P28223 4/20 0.52
HTR6 P50406 4/20 0.52
DRD3 P35462 3/20 0.49
DRD4 P21917 1/20 0.49
DRD5 P21918 1/20 0.49
ALDH1A1 P00352 2/20 0.47
POLB P06746 1/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7104527 0.87 HTR7 (0.54) HTR7DRD2HTR1AHTR2AHTR6
SCHEMBL7110321 0.82 HTR7 (0.45) HTR7DRD2HTR1AHTR2AHTR6
SCHEMBL7105893 0.77 CYP2D6 (0.52) HTR7HTR2AHTR6CYP1A2CYP2C19
SCHEMBL7109458 0.77 HTR7 (0.49) HTR7DRD2HTR1AHTR2AHTR6
Ethylene SCHEMBL6997843 0.77 DRD2 (0.44) HTR7DRD2HTR1AHTR2AHTR6
SCHEMBL6985770 0.76 HTR7 (0.49) HTR7DRD2HTR1AHTR2AHTR6
SCHEMBL6997228 0.75 HTR7 (0.49) HTR7DRD2HTR1AHTR2AHTR6
SCHEMBL7103149 0.75 HTR7 (0.38) HTR7DRD2HTR1AHTR2AHTR6
SCHEMBL6996766 0.75 DRD2 (0.54) HTR7DRD2HTR1AHTR2AHTR6
SCHEMBL6997847 0.74 HTR7 (0.47) HTR7DRD2HTR1AHTR2AHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6664251-B2 Serotonin receptor antagonist; treating cardiovascular disorder DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2003-12-16 US disclosed
US-20030078256-A1 Benzothiazine derivative SUNTORY LIMITED (JP) 2003-04-24 US disclosed
US-6316442-B1 TREATMENT OF HEART DISEASE AND CEREBROVASCULAR DISTURBANCES SUNTORY LIMITED (JP) 2001-11-13 US disclosed
US-6001827-A Benzothiazine derivative SUNTORY LIMITED (JP) 1999-12-14 US disclosed
EP-0749967-A1 Substituted benzothiazine derivative SUNTORY LIMITED (JP) 1996-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078256-A1 Benzothiazine derivative TPH2, ADRB2, TPH1 HTR7 24/4885DRD2 402/4885HTR1A 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.